Missouri 2023 2023 Regular Session

Missouri House Bill HB198 Introduced / Fiscal Note

                    COMMITTEE ON LEGISLATIVE RESEARCH
OVERSIGHT DIVISION
FISCAL NOTE
L.R. No.:0545H.01I Bill No.:HB 198  Subject:Pharmacy; Insurance - Health Type:Original  Date:March 27, 2023Bill Summary:This proposal creates provisions relating to insurance coverage of pharmacy 
services. 
FISCAL SUMMARY
ESTIMATED NET EFFECT ON GENERAL REVENUE FUNDFUND 
AFFECTED
FY 2024FY 2025FY 2026General Revenue 
Fund*
(Unknown, could 
exceed $10,980,000)
(Unknown, could 
exceed $10,980,000)
(Unknown, could 
exceed $10,980,000)
Total Estimated 
Net Effect on 
General 
Revenue
(Unknown, could 
exceed $10,980,000)
(Unknown, could 
exceed $10,980,000)
(Unknown, could 
exceed $10,980,000)
* The fiscal impact is unknown, however, MCHCP estimates that it would be greater than $18 
million split between General Revenue, Other Funds and Federal Funds.
ESTIMATED NET EFFECT ON OTHER STATE FUNDSFUND 
AFFECTED
FY 2024FY 2025FY 2026
Other Funds
(Unknown, could 
exceed $2,520,000)
(Unknown, could 
exceed $2,520,000)
(Unknown, could 
exceed $2,520,000)
Total Estimated 
Net Effect on 
Other State 
Funds(Unknown, could 
exceed $2,520,000)
(Unknown, could 
exceed $2,520,000)
(Unknown, could 
exceed $2,520,000)
Numbers within parentheses: () indicate costs or losses. L.R. No. 0545H.01I 
Bill No. HB 198  
Page 2 of 
March 27, 2023
HWC:LR:OD
ESTIMATED NET EFFECT ON FEDERAL FUNDSFUND 
AFFECTED
FY 2024FY 2025FY 2026Federal Funds(Unknown, could 
exceed $4,500,000)
(Unknown, could 
exceed $4,500,000)
(Unknown, could 
exceed $4,500,000)
Total Estimated 
Net Effect on All 
Federal Funds(Unknown, could 
exceed $4,500,000)
(Unknown, could 
exceed $4,500,000)
(Unknown, could 
exceed $4,500,000)
ESTIMATED NET EFFECT ON FULL TIME EQUIVALENT (FTE)FUND AFFECTEDFY 2024FY 2025FY 2026Total Estimated Net 
Effect on FTE 000
☒ Estimated Net Effect (expenditures or reduced revenues) expected to exceed $250,000 in any  
     of the three fiscal years after implementation of the act or at full implementation of the act.
☐ Estimated Net Effect (savings or increased revenues) expected to exceed $250,000 in any of
     the three fiscal years after implementation of the act or at full implementation of the act.
ESTIMATED NET EFFECT ON LOCAL FUNDSFUND AFFECTEDFY 2024FY 2025FY 2026Local Government(Unknown)(Unknown)(Unknown) L.R. No. 0545H.01I 
Bill No. HB 198  
Page 3 of 
March 27, 2023
HWC:LR:OD
FISCAL ANALYSIS
ASSUMPTION
§376.411 – Insurance coverage of pharmacy services
Officials from the Missouri Consolidated Health Care Plan (MCHCP) state that MCHCP is 
not a health care plan under the definition of §376.1350.  However, §104.801, requires MCHCP 
to follow any law which mandates coverage of specific health benefits, services or providers. 
Since this legislation is mandating providers, MCHCP assumes it does apply to MCHCP.
Section 376.411, mandates that every pharmacy and provider be treated the same when covering 
clinician-administered drugs. Today MCHCP uses several channel management programs to 
provide drugs at the lowest cost possible. This bill would restrict usage of these programs and, as 
a result, MCHCP costs could increase by limiting MCHCP’s ability to direct coverage under the 
channel with the lower cost. MCHCP pharmacy benefit manager currently estimates that it saves 
around $39 million from these programs. The fiscal impact is unknown, but MCHCP estimates 
that it would be greater than $18 million.
Oversight assumes this legislation applies to MCHCP and, therefore, will reflect MCHCP’s 
estimate of an unknown loss, possibly exceeding $18 million to the General Revenue Fund, 
Other State Funds and Federal Funds.
General Revenue$10,980,00061%Federal Funds$4,500,00025%Other Funds$2,520,00014%Total$18,000,000100%
*MCHCP Fund Split Percentages provided by Budget & Planning
Oversight assumes this provision could have a fiscal impact on local government health plans 
and, therefore, will reflect an unknown loss to local political subdivisions.
Officials from the Missouri Department of Transportation (MoDOT) assume the proposal 
will have no fiscal impact on their organization or the MoDOT/DPS-MSHP health plan.  
Officials from the Department of Commerce and Insurance, the Department of Social 
ServicesMissouri Department of Conservation, the City of Kansas City and the City of 
Springfield each assume the proposal will have no fiscal impact on their respective 
organizations. Oversight does not have any information to the contrary. Therefore, Oversight 
will reflect a zero impact in the fiscal note for these agencies.  L.R. No. 0545H.01I 
Bill No. HB 198  
Page 4 of 
March 27, 2023
HWC:LR:OD
Officials from the Department of Public Safety, Missouri Highway Patrol defer to the 
MoDOT/MHP Health Care Board for response relating to the fiscal impact of this proposal on 
their organization.
Oversight only reflects the responses received from state agencies and political subdivisions; 
however, other cities and various county officials were requested to respond to this proposed 
legislation but did not. A listing of political subdivisions included in the Missouri Legislative 
Information System (MOLIS) database is available upon request.
FISCAL IMPACT – State 
Government
FY 2024
(10 Mo.)
FY 2025FY 2026GENERAL REVEUE 
FUND
Loss – MCHCP
   Elimination of channel 
management programs 
(§376.411)
(Unknown, could 
exceed 
$10,980,000)
(Unknown, could 
exceed 
$$10,980,000)
(Unknown, could 
exceed 
$$10,980,000)
ESTIMATED NET 
EFFECT TO THE 
GENERAL REVENUE 
FUND
(Unknown, could 
exceed 
$10,980,000)
(Unknown, could 
exceed 
$$10,980,000)
(Unknown, could 
exceed 
$$10,980,000)
OTHER FUNDSLoss – MCHCP
   Elimination of channel 
management programs 
(§376.411)
(Unknown, could 
exceed $2,520,000)
(Unknown, could 
exceed $2,520,000)
(Unknown, could 
exceed $2,520,000)
ESTIMATED NET 
EFFECT TO OTHER 
FUNDS
(Unknown, could 
exceed $2,520,000)
(Unknown, could 
exceed $2,520,000)
(Unknown, could 
exceed $2,520,000) L.R. No. 0545H.01I 
Bill No. HB 198  
Page 5 of 
March 27, 2023
HWC:LR:OD
FISCAL IMPACT – State 
Government (continued)
FY 2024
(10 Mo.)
FY 2025FY 2026FEDERAL FUNDSLoss – MCHCP
   Elimination of channel 
management programs 
(§376.411)
(Unknown, could 
exceed $4,500,000)
(Unknown, could 
exceed $4,500,000)
(Unknown, could 
exceed $4,500,000)
ESTIMATED NET 
EFFECT TO FEDERAL 
FUNDS
(Unknown, could 
exceed $4,500,000)
(Unknown, could 
exceed $4,500,000)
(Unknown, could 
exceed $4,500,000)
FISCAL IMPACT – Local GovernmentFY 2024
(10 Mo.)
FY 2025FY 2026LOCAL POLITICAL 
SUBDIVISIONS
Loss –  Local Political Subdivisions 
Elimination of channel management 
programs (§376.411)(Unknown)(Unknown)(Unknown)
ESTIMATED NET EFFECT TO 
LOCAL POLITICAL 
SUDBVISIONS(Unknown)(Unknown)(Unknown)
FISCAL IMPACT – Small Business
No direct fiscal impact to small businesses would be expected as a result of this proposal.
FISCAL DESCRIPTION
This bill establishes requirements for insurance coverage of certain pharmacy services. This bill 
provides that a health carrier, pharmacy benefits manager, or agent of such entities are prohibited 
from imposing any penalty, impediment, differentiation, or limitation on:  L.R. No. 0545H.01I 
Bill No. HB 198  
Page 6 of 
March 27, 2023
HWC:LR:OD
(1) Participating providers for providing medically necessary clinician-administered drugs, 
regardless of whether the participating provider obtains such drugs from a provider that is in the 
network; 
(2) A person who is administered medically necessary clinician administered drugs regardless of 
whether the participating provider obtains such drugs from a provider that is in the network; or 
(3) Any pharmacy, including any class B hospital pharmacy as defined in Section 338.220, 
RSMo, which is dispensing medically necessary clinician-administered drugs regardless of 
whether the participating provider obtains such drugs from a provider that is in the network. 
This prohibition does not apply if the clinician-administered drug is not otherwise covered by the 
health carrier or pharmacy benefits manager.
 A health carrier, pharmacy benefits manager, or agent of such entities may not discriminate, 
lower the reimbursement, or impose any separate contract terms upon an entity based upon that 
entity's participation in the 340B drug pricing program, described in 42 U.S.C. Section 256b, or 
limit a patient's freedom to use any such entity, as described in the bill. 
All pharmacy claims processed by a pharmacy that participates in the 340B drug pricing program 
are final at the point of adjudication. 
This bill defines "biological product", "biosimilar product", and "reference product" as having 
the same meaning as given to the terms under federal law. A health carrier, pharmacy benefits 
manager, or agent of such entities that provides coverage for a reference product or biosimilar 
biological product must provide coverage for the reference product and all biological products 
that have been deemed biosimilar to the reference product.
This legislation is not federally mandated, would not duplicate any other program and would not 
require additional capital improvements or rental space. L.R. No. 0545H.01I 
Bill No. HB 198  
Page 7 of 
March 27, 2023
HWC:LR:OD
SOURCES OF INFORMATION
Department of Commerce and Insurance
Department of Public Safety –
Missouri Highway Patrol
Department of Social Services
Missouri Department of Conservation
Missouri Department of Transportation
Missouri Consolidated Health Care Plan
City of Kansas City
City of Springfield
Julie MorffRoss StropeDirectorAssistant DirectorMarch 27, 2023March 27, 2023